HomeOur expertisePostersACoP 2024, Phoenix, AZ, USMechanistic translational modeling versus minimal anticipated biological effect level approach to predict first-in-human dose for T-cell engagers: HPN536 case study
We use cookies (and other similar technologies) to collect data to improve your experience on our site.
By using our website, you agree to data collection as described in our website’s data collection policy.